February 24, 2023false000157454000015745402023-02-242023-02-24

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K

 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): February 24, 2023
 
 PHYSICIANS REALTY TRUST
(Exact name of registrant as specified in its charter)
 
Maryland001-3600746-2519850
(State of Organization)(Commission File Number)(IRS Employer Identification No.)
 
309 N. Water Street, Suite 50053202
MilwaukeeWisconsin
(Address of Principal Executive Offices)(Zip Code)

Registrant’s telephone number, including area code: (414) 367-5600
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common stock, $0.01 par value per shareDOCNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o


Item 8.01. Other Events

On February 24, 2023, Physicians Realty Trust (the “Company”) and its operating partnership, Physicians Realty L.P., filed with the Securities and Exchange Commission (the “SEC”) an automatic shelf registration statement on Form S-3ASR (No. 333-269992) (the “New Registration Statement”), which replaced the existing automatic shelf registration statement on Form S-3ASR (No. 333-236725) filed with the SEC on February 27, 2020 (the “Prior Registration Statement”).

In connection with the filing of the New Registration Statement, the Company filed on February 24, 2023 (i) a prospectus supplement covering the sale of the common shares of beneficial interest in the Company (“Common Shares”) having aggregate sales proceeds of up to $158,622,656 through each of BMO Capital Markets Corp., Credit Agricole Securities (USA) Inc., KeyBanc Capital Markets Inc. and Raymond James & Associates, Inc. as sales agents for the Company and/or forward sellers and Stifel, Nicolaus & Company, Incorporated as sales agent for the Company and Bank of Montreal, Credit Agricole Corporate and Investment Bank, KeyBanc Capital Markets Inc. and Raymond James & Associates, Inc. as forward purchasers for the Company, from time to time, by any method deemed to be an “at the market offering” as defined in Rule 415 under the Securities Act of 1933, as amended (the “ATM Program”), which was filed solely to continue the sale of Common Shares that remain unsold pursuant to the Company’s ATM program, which were previously registered under the Prior Registration Statement and (ii) a prospectus supplement covering the sale of the 1,283,034 Common Shares remaining available for issuance under the Company’s Dividend Reinvestment and Share Purchase Plan (the “DRIP”), which Common Shares were previously registered under the Prior Registration Statement.

The following documents are being filed with this Current Report on Form 8-K and are incorporated by reference into the New Registration Statement: (i) validity opinions with respect to the Common Shares and (ii) an opinion with respect to tax matters.

Item 9.01. Financial Statement and Exhibits.

(d)  Exhibits.
23.1Consent of Venable LLP (included in Exhibits 5.1 and 5.2 above)
23.2Consent of Baker & McKenzie LLP (included in Exhibits 8.1 and 8.2 above)
104Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Date:February 24, 2023 PHYSICIANS REALTY TRUST
   
   
 By:/s/ John T. Thomas
  John T. Thomas
  President and Chief Executive Officer




EXHIBIT INDEX
 
Exhibit No. Description
   
23.1 Consent of Venable LLP (included in Exhibits 5.1 and 5.2 above)
23.2Consent of Baker & McKenzie LLP (included in Exhibits 8.1 and 8.2 above)
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Exhibit 5.1
venablelogov1.jpg

February 24, 2023

Physicians Realty Trust
309 N. Water Street, Suite 500
Milwaukee, Wisconsin 53202

Re: Registration Statement on Form S-3


Ladies and Gentlemen:
We have served as Maryland counsel to Physicians Realty Trust, a Maryland real estate investment trust (the “Company”), in connection with certain matters of Maryland law relating to the sale and issuance by the Company of common shares (the “Shares”) of beneficial interest, $0.01 par value per share (the “Common Shares”), of the Company, having a maximum aggregate offering price of $500,000,000, in at-the-market offerings, of which $158,622,656 remains available, covered by the above-referenced Registration Statement, and all amendments related thereto (the “Registration Statement”), filed by the Company with the United States Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “1933 Act”). The Shares are to be issued pursuant to either (a) Sales Agreements (as defined below) or (b) one or more Master Confirmations (the “Master Confirmations” and, together with the Sales Agreements, the “Agreements”), which may be entered into after the date hereof in accordance with each Sale Agreement.

In connection with our representation of the Company, and as a basis for the opinion hereinafter set forth, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the following documents (hereinafter collectively referred to as the Documents”):
1.The Registration Statement and the related form of prospectus included therein;

2.The Prospectus Supplement, dated as of the date hereof (the “Prospectus Supplement”), in the form to be filed with the Commission pursuant to Rule 424(b) of the General Rules and Regulations promulgated under the 1933 Act;

3.The declaration of trust of the Company (the “Declaration”), certified by the State Department of Assessments and Taxation of Maryland (the “SDAT”);

4.The Bylaws of the Company, certified as of the date hereof by an officer of the Company;

5.The At Market Issuance Sales Agreements, each dated as of May 7, 2021(the “Sales Agreements”), by and among the Company, Physicians Realty L.P., a Delaware limited Partnership, and each of BMO Capital Markets Corp., Credit Agricole Securities (USA) Inc., KeyBanc Capital Markets Inc. and Raymond James & Associates, Inc., as agents

venablelogov2.jpg
Physicians Realty Trust
February 24, 2023
Page 2
and forward sellers, and Stifel, Nicolaus & Company, Incorporated, as agent, and Bank of Montreal, Credit Agricole Corporate and Investment Bank, KeyBanc Capital Markets Inc. and Raymond James & Associates, Inc., each a forward purchaser,;

6.The form of Master Confirmation, included as a schedule to each of the Sales Agreements, to be executed in connection with the issuance of any Shares pursuant thereto (the Shares so issued, the “Forward Shares”);

7.The form of Supplemental Confirmation, included as an exhibit to the form of Master Confirmation (the “Supplemental Confirmation”), to be executed in connection with the issuance of any Forward Shares;

8.A certificate of the SDAT as to the good standing of the Company, dated as of a recent date;

9.Resolutions adopted by the Board of Trustees (the “Board”) of the Company, or by a duly authorized committee of the Board (the “Board Resolutions”), relating among other matters, (i) the authorization of the issuance of the Shares, (ii) the Agreements and (iii) the delegation to designated officers of the Company (the “Authorized Officers”) of the power to determine the number and price of the Shares and certain other matters in connection with the registration, sale and issuance of the Shares, certified as of the date hereof by an officer of the Company;

10.A certificate executed by an officer of the Company, dated as of the date hereof; and

11.Such other documents and matters as we have deemed necessary or appropriate to express the opinion set forth below, subject to the assumptions, limitations and qualifications stated herein.

In expressing the opinion set forth below, we have assumed the following:

1.Each individual executing any of the Documents, whether on behalf of such individual or another person, is legally competent to do so.

2.Each individual executing any of the Documents on behalf of a party (other than the Company) is duly authorized to do so.

3.Each of the parties (other than the Company) executing any of the Documents has duly and validly executed and delivered each of the Documents to which such party is a signatory, and such party’s obligations set forth therein are legal, valid and binding and are enforceable in accordance with all stated terms.

venablelogov2.jpg
Physicians Realty Trust
February 24, 2023
Page 3
4.All Documents submitted to us as originals are authentic. The form and content of all Documents submitted to us as unexecuted drafts do not differ in any respect relevant to this opinion from the form and content of such Documents as executed and delivered. All Documents submitted to us as certified or photostatic copies conform to the original documents. All signatures on all Documents are genuine. All public records reviewed or relied upon by us or on our behalf are true and complete. All representations, warranties, statements and information contained in the Documents are true and complete. There has been no oral or written modification of or amendment to any of the Documents, and there has been no waiver of any provision of any of the Documents, by action or omission of the parties or otherwise.

5.The Shares will not be issued or transferred in violation of the restrictions on transfer and ownership contained in Article VII of the Declaration.

6.Upon the issuance of any Shares, the total number of Common Shares issued and outstanding will not exceed the total number of Common Shares that the Company is then authorized to issue under the Declaration.

7.Certain terms of the Shares to be issued by the Company from time to time will be authorized and approved by the Board or a duly authorized committee thereof, or by the Authorized Officers, in accordance with the Maryland REIT Law, the Declaration, the Bylaws, the Sales Agreements or the Master Confirmations (and related Supplemental Confirmation), as applicable, and the Board Resolutions (with such approvals referred to hereinafter as the “Trust Proceedings”) prior to the issuance thereof.

Based upon the foregoing, and subject to the assumptions, limitations and qualifications stated herein, it is our opinion that:

1.The Company is a real estate investment trust duly formed and existing under and by virtue of the laws of the State of Maryland and is in good standing with the SDAT.

2.The issuance of the Shares has been duly authorized and, when issued and delivered by the Company in accordance with the Trust Proceedings, the Board Resolutions, the Declaration, the Prospectus Supplement, the Sales Agreements or the Master Confirmations (and related Supplemental Confirmation), as applicable, and the Registration Statement against payment of the consideration set forth therein, the Shares will be validly issued, fully paid and nonassessable.

The foregoing opinion is limited to the laws of the State of Maryland and we do not express any opinion herein concerning federal law or the laws of any other state. We express no opinion as to the applicability or effect of federal or state securities laws, including the securities laws of the

venablelogov2.jpg
Physicians Realty Trust
February 24, 2023
Page 4
State of Maryland, or as to federal or state laws regarding fraudulent transfers. To the extent that any matter as to which our opinion is expressed herein would be governed by the laws of any jurisdiction other than the State of Maryland, we do not express any opinion on such matter. The opinion expressed herein is subject to the effect of any judicial decision which may permit the introduction of parol evidence to modify the terms or the interpretation of agreements.

The opinion expressed herein is limited to the matters specifically set forth herein and no other opinion shall be inferred beyond the matters expressly stated. We assume no obligation to supplement this opinion if any applicable law changes after the date hereof or if we become aware of any fact that might change the opinion expressed herein after the date hereof.

This opinion is being furnished to you for submission to the Commission as an exhibit to the Company’s Current Report on Form 8-K relating to the Shares (the “Current Report”). We hereby consent to the filing of this opinion as an exhibit to the Current Report and to the use of the name of our firm therein. In giving this consent, we do not admit that we are within the category of persons whose consent is required by Section 7 of the 1933 Act.



Very truly yours,

/s/ Venable LLP

VENABLE LLP
Exhibit 5.2
venablelogov1.jpg


February 24, 2023

Physicians Realty Trust
309 N. Water Street, Suite 500
Milwaukee, Wisconsin 53202

Re: Registration Statement on Form S-3

Ladies and Gentlemen:

We have served as Maryland counsel to Physicians Realty Trust, a Maryland real estate investment trust (the “Company”), in connection with certain matters of Maryland law arising out of the registration of 1,283,034 common shares (the “Shares”) of beneficial interest, $0.01 par value per share (“Common Shares”), of the Company to be issued by the Company in accordance with its Dividend Reinvestment and Share Purchase Plan (the “Plan”). The Shares are covered by the above-referenced Registration Statement, and all amendments thereto (the “Registration Statement”), filed by the Company with the United States Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “1933 Act”), on or about the date hereof.

In connection with our representation of the Company, and as a basis for the opinion hereinafter set forth, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the following documents (herein collectively referred to as the “Documents”):

1. The Registration Statement and the related form of prospectus included therein in the form in which it was transmitted to the Commission under the 1933 Act;

2.The Prospectus Supplement, substantially in the form to be filed by the Company with the Commission pursuant to Rule 424(b) under the 1933 Act;

3.The declaration of trust of the Company (the “Declaration of Trust”), certified by the State Department of Assessments and Taxation of Maryland (the “SDAT”);

4.The Bylaws of the Company, certified as of the date hereof by an officer of the Company;

5.A certificate of the SDAT as to the good standing of the Company, dated as of a recent date;







venablelogov2.jpg
Physicians Realty Trust
February 24, 2023
Page 2



6. Resolutions adopted by the Board of Trustees of the Company relating to, among other matters, the issuance of the Shares (the “Resolutions”), certified as of the date hereof by an officer of the Company;

7.The Plan;

8.A certificate executed by an officer of the Company, dated as of the date hereof; and

9.Such other documents and matters as we have deemed necessary or appropriate to express the opinion set forth below, subject to the assumptions, limitations and qualifications stated herein.

In expressing the opinion set forth below, we have assumed the following:

1. Each individual executing any of the Documents, whether on behalf of such individual or another person, is legally competent to do so.

2.Each individual executing any of the Documents on behalf of a party (other than the Company) is duly authorized to do so.

3.Each of the parties (other than the Company) executing any of the Documents has duly and validly executed and delivered each of the Documents to which such party is a signatory, and such party’s obligations set forth therein are legal, valid and binding and are enforceable in accordance with all stated terms.

4.All Documents submitted to us as originals are authentic. The form and content of all Documents submitted to us as unexecuted drafts do not differ in any respect relevant to this opinion from the form and content of such Documents as executed and delivered. All Documents submitted to us as certified or photostatic copies conform to the original documents. All signatures on all Documents are genuine. All public records reviewed or relied upon by us or on our behalf are true and complete. All representations, warranties, statements and information contained in the Documents are true and complete. There has been no oral or written modification of or amendment to any of the Documents, and there has been no waiver of any provision of any of the Documents, by action or omission of the parties or otherwise.

5.Upon any issuance of the Shares the total number of Common Shares issued and outstanding will not exceed the total number of Common Shares that the Company is then authorized to issue under the Declaration of Trust.



venablelogov2.jpg
Physicians Realty Trust
February 24, 2023
Page 3



6. None of the Shares will be issued, sold or transferred in violation of the restrictions on ownership and transfer set forth in Article VII of the Declaration of Trust.

Based upon the foregoing, and subject to the assumptions, limitations and qualifications stated herein, it is our opinion that:

1.The Company is a real estate investment trust duly formed and existing under and by virtue of the laws of the State of Maryland and is in good standing with the SDAT.

2.The issuance of the Shares has been duly authorized and, when issued and delivered against payment therefor in accordance with the Resolutions, the Plan and the Registration Statement, the Shares will be validly issued, fully paid and nonassessable.

The foregoing opinion is limited to the laws of the State of Maryland and we do not express any opinion herein concerning federal law or the laws of any other state. We express no opinion as to compliance with any federal or state securities laws, including the securities laws of the State of Maryland, or as to federal or state laws regarding fraudulent transfers. To the extent that any matter as to which our opinion is expressed herein would be governed by the laws of any jurisdiction other than the State of Maryland, we do not express any opinion on such matter. The opinion expressed herein is subject to the effect of judicial decisions which may permit the introduction of parol evidence to modify the terms or the interpretation of agreements.

The opinion expressed herein is limited to the matters specifically set forth herein and no other opinion shall be inferred beyond the matters expressly stated. We assume no obligation to supplement this opinion if any applicable law changes after the date hereof or if we become aware of any fact that might change the opinion expressed herein after the date hereof.

This opinion is being furnished to you for submission to the Commission as an exhibit to the Company’s Current Report on Form 8-K relating to the Shares (the “Current Report”). We hereby consent to the filing of this opinion as an exhibit to the Current Report and to the use of the name of our firm therein. In giving this consent, we do not admit that we are within the category of persons whose consent is required by Section 7 of the 1933 Act.


Very truly yours,

/s/ Venable LLP

VENABLE LLP
Exhibit 8.1
bakermckenzielogo.jpg
bakermckenzielogo2.jpg
February 24, 2023
 
Physicians Realty Trust
309 N. Water Street
Suite 500
Milwaukee, WI 53202

Re: Physicians Realty Trust Qualification as Real Estate Investment Trust

We have acted as U.S. federal income tax counsel for Physicians Realty Trust, a Maryland real estate investment trust (the “Company”), and Physicians Realty L.P., a Delaware limited partnership (together with the Company, the “Opinion Parties”), in connection with the issuance and sale, from time to time, of common shares of the Company, par value of $0.01 per share, with an aggregate sales price of up to $158,622,656 (the “Shares”). The Shares are being registered pursuant to the Registration Statement on Form S-3ASR, as amended through the date hereof (the
“Registration Statement”), that was filed on behalf of the Opinion Parties with the Securities and Exchange Commission (the “SEC”) on February 24, 2023. You have requested our opinion regarding certain U.S. federal income tax matters.

In connection with the opinions rendered below, we have examined the following:

1)the Company’s Declaration of Trust;

2)the Company’s Bylaws;

3)the Registration Statement;

4)the prospectus relating to the offering of securities of the Opinion Parties that forms a part of and is included in the Registration Statement (the “Base Prospectus”), as supplemented by the prospectus supplement dated February 24, 2023 relating to the registration of the Shares (the “Prospectus Supplement”); and

5)such other documents as we have deemed necessary or appropriate for purposes of this opinion.



Baker & McKenzie LLP is a member of Baker & McKenzie International.

In connection with the opinions rendered below, we have assumed generally that:

1)Each of the documents referred to above has been duly authorized, executed and delivered; is authentic, if an original, or is accurate, if a copy; and has not been amended.

2)During the Company’s fiscal years ended December 31, 2018, December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022 and subsequent fiscal years, the Company, the partnerships and the corporations in which the Company owns an interest (respectively, the “Partnerships” and “Corporations”) have operated and will continue to operate in such a manner that makes and will continue to make the factual representations contained in a certificate, dated as of the date hereof and executed by a duly appointed officer of the Company (the “Officer’s Certificate”), true for such years.

3)No amendments to the organizational documents of the Company, the Partnerships and the Corporations will be made after the date of this opinion that would affect the Company’s qualification as a real estate investment trust (a “REIT”) for any taxable year.

4)No action will be taken by the Company, the Partnerships or the Corporations after the date hereof that would have the effect of altering the facts upon which the opinions set forth below are based.

In connection with the opinions rendered below, we also have relied upon the correctness of the factual representations contained in the Officer’s Certificate.After reasonable inquiry, we are not aware of any facts inconsistent with the factual representations set forth in the Officer’s Certificate.

Based on the documents and assumptions set forth above, the representations set forth in the Officer’s Certificate and the factual matters in the discussion in the Base Prospectus under the caption “Material U.S. Federal Income Tax Considerations,” as supplemented by the discussion in the Prospectus Supplement under the caption “Additional U.S. Federal Income Tax Considerations” (which discussions are incorporated herein by reference), we are of the opinion that:

a)the Company qualified to be taxed as a REIT pursuant to sections 856 through 860 of the Internal Revenue Code of 1986, as amended (the “Code”), for its fiscal years ended December 31, 2018, December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022, and the Company’s organization and current method of operation will enable it to continue to qualify to be taxed as a REIT for its current fiscal year ending December 31, 2023 and in the future;
2

b)the statements contained in the Base Prospectus under the caption “Material U.S. Federal Income Tax Considerations” and in the Prospectus Supplement under the caption “Additional U.S. Federal Income Tax Considerations,” insofar as such statements constitute matters of law, summaries of legal matters, or legal conclusions, have been reviewed by us and fairly present and summarize, in all material respects, the matters referred to therein.

We will not review on a continuing basis the Company’s compliance with the documents or assumptions set forth above, or the representations set forth in the Officer’s Certificate. Accordingly, no assurance can be given that the actual results of the Company’s operations for its fiscal year ending December 31, 2023, and subsequent fiscal years, will satisfy the requirements for qualification and taxation as a REIT.
 
We also note that the tax consequences addressed herein depend upon the actual occurrence of events in the future, which events may or may not be consistent with any representations or covenants made to us for purposes of this opinion. In particular, the qualification and taxation of the Company as a REIT for U.S. federal income tax purposes depend upon the Company’s ability to meet on a continuing basis certain distribution levels, diversity of stock ownership, and the various qualification tests imposed by the Code. To the extent that the facts differ from those represented to or assumed by us herein, our opinion should not be relied upon.

Our opinion is based on existing law as contained in the Code, final and temporary Treasury Regulations promulgated thereunder, administrative pronouncements of the Internal Revenue Service (the “IRS”) and court decisions as of the date hereof. The provisions of the Code and the Treasury Regulations, IRS administrative pronouncements and case law, upon which this opinion is based, could change at any time, possibly with retroactive effect. In addition, some of the issues under existing law that could significantly affect our opinion have not yet been authoritatively addressed by the IRS or the courts, and our opinion is not binding on the IRS or the courts. Hence, there can be no assurance that the IRS will not challenge, or that the courts will agree, with our conclusions.

We have acted solely as U.S. federal income tax counsel to the Company with respect to the filing of the Registration Statement. The foregoing opinions are limited to the U.S. federal income tax matters addressed herein, and no other opinions are rendered with respect to other U.S. federal tax matters or to any issues arising under the tax laws of any other country, or any state or locality. We have also not considered any non-tax matters. We undertake no obligation to update the opinions expressed herein after the date of this letter.

We hereby consent to the filing of this opinion as an exhibit to the Company’s current report on Form 8-K to be filed with the SEC and the use of the name of our firm therein. In giving this consent, we do not acknowledge that we are in the category of persons whose consent is required by Section 7 of the Securities Act of 1933, as amended, or the rules and regulations promulgated thereunder by the SEC.


Very truly yours,

/s/ Baker & McKenzie LLP





3
Exhibit 8.2
bakermckenzielogo.jpg
bakermckenzielogo2.jpg
February 24, 2023

Physicians Realty Trust
309 N. Water Street
Suite 500
Milwaukee, WI 53202

Re: Physicians Realty Trust Qualification as Real Estate Investment Trust

We have acted as U.S. federal income tax counsel for Physicians Realty Trust, a Maryland real estate investment trust (the “Company”), and Physicians Realty L.P., a Delaware limited partnership (together with the Company, the “Opinion Parties”), in connection with the registration of 1,283,034 of the Company’s common shares, par value $0.01 per share (the “Shares”), to be issued by the Company in accordance with its Dividend Reinvestment and Share Purchase Plan. The Shares are being registered pursuant to the Registration Statement on Form S-3ASR, as amended through the date hereof (the “Registration Statement”), that was filed on behalf of the Opinion Parties with the Securities and Exchange Commission (the “SEC”) on February 24, 2023. You have requested our opinion regarding certain U.S. federal income tax matters.

In connection with the opinions rendered below, we have examined the following:

1)the Company’s Declaration of Trust;

2)the Company’s Bylaws;

3)the Registration Statement;

4)the prospectus relating to the offering of securities of the Opinion Parties that forms a part of and is included in the Registration Statement (the “Base Prospectus”), as supplemented by the prospectus supplement dated February 24, 2023 relating to the registration of the Shares (the “Prospectus Supplement”); and

5)such other documents as we have deemed necessary or appropriate for purposes of this opinion.



Baker & McKenzie LLP is a member of Baker & McKenzie International.

In connection with the opinions rendered below, we have assumed generally that:

1)Each of the documents referred to above has been duly authorized, executed and delivered; is authentic, if an original, or is accurate, if a copy; and has not been amended.

2)During the Company’s fiscal years ended December 31, 2018, December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022 and subsequent fiscal years, the Company, the partnerships and the corporations in which the Company owns an interest (respectively, the “Partnerships” and “Corporations”) have operated and will continue to operate in such a manner that makes and will continue to make the factual representations contained in a certificate, dated as of the date hereof and executed by a duly appointed officer of the Company (the “Officer’s Certificate”), true for such years.

3)No amendments to the organizational documents of the Company, the Partnerships and the Corporations will be made after the date of this opinion that would affect the Company’s qualification as a real estate investment trust (a “REIT”) for any taxable year.

4)No action will be taken by the Company, the Partnerships or the Corporations after the date hereof that would have the effect of altering the facts upon which the opinions set forth below are based.

In connection with the opinions rendered below, we also have relied upon the correctness of the factual representations contained in the Officer’s Certificate. After reasonable inquiry, we are not aware of any facts inconsistent with the factual representations set forth in the Officer’s Certificate.

Based on the documents and assumptions set forth above, the representations set forth in the Officer’s Certificate and the factual matters in the discussion in the Base Prospectus under the caption “Material U.S. Federal Income Tax Considerations,” as supplemented by the discussion in the Prospectus Supplement under the caption “Additional U.S. Federal Income Tax Considerations” (which discussions are incorporated herein by reference), we are of the opinion that:

a)the Company qualified to be taxed as a REIT pursuant to sections 856 through 860 of the Internal Revenue Code of 1986, as amended (the “Code”), for its fiscal years ended December 31, 2018, December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022, and the Company’s organization and current method of operation will enable it to continue to qualify to be taxed as a REIT for its current fiscal year ending December 31, 2023 and in the future;
2

b)the statements contained in the Base Prospectus under the caption “Material U.S. Federal Income Tax Considerations” and in the Prospectus Supplement under the caption “Additional U.S. Federal Income Tax Considerations,” insofar as such statements constitute matters of law, summaries of legal matters, or legal conclusions, have been reviewed by us and fairly present and summarize, in all material respects, the matters referred to therein.

We will not review on a continuing basis the Company’s compliance with the documents or assumptions set forth above, or the representations set forth in the Officer’s Certificate. Accordingly, no assurance can be given that the actual results of the Company’s operations for its fiscal year ending December 31, 2023, and subsequent fiscal years, will satisfy the requirements for qualification and taxation as a REIT.

We also note that the tax consequences addressed herein depend upon the actual occurrence of events in the future, which events may or may not be consistent with any representations or covenants made to us for purposes of this opinion. In particular, the qualification and taxation of the Company as a REIT for U.S. federal income tax purposes depend upon the Company’s ability to meet on a continuing basis certain distribution levels, diversity of stock ownership, and the various qualification tests imposed by the Code. To the extent that the facts differ from those represented to or assumed by us herein, our opinion should not be relied upon.

Our opinion is based on existing law as contained in the Code, final and temporary Treasury Regulations promulgated thereunder, administrative pronouncements of the Internal Revenue Service (the “IRS”) and court decisions as of the date hereof. The provisions of the Code and the Treasury Regulations, IRS administrative pronouncements and case law, upon which this opinion is based, could change at any time, possibly with retroactive effect. In addition, some of the issues under existing law that could significantly affect our opinion have not yet been authoritatively addressed by the IRS or the courts, and our opinion is not binding on the IRS or the courts. Hence, there can be no assurance that the IRS will not challenge, or that the courts will agree, with our conclusions.

We have acted solely as U.S. federal income tax counsel to the Company with respect to the filing of the Registration Statement. The foregoing opinions are limited to the U.S. federal income tax matters addressed herein, and no other opinions are rendered with respect to other U.S. federal tax matters or to any issues arising under the tax laws of any other country, or any state or locality. We have also not considered any non-tax matters. We undertake no obligation to update the opinions expressed herein after the date of this letter.

We hereby consent to the filing of this opinion as an exhibit to the Company’s current report on Form 8-K to be filed with the SEC and the use of the name of our firm therein. In giving this consent, we do not acknowledge that we are in the category of persons whose consent is required by Section 7 of the Securities Act of 1933, as amended, or the rules and regulations promulgated thereunder by the SEC.


Very truly yours,


/s/ Baker & McKenzie LLP






3